NasdaqGS:VRTXBiotechs
Can Vertex Stock Bounce Back After 17% Drop and Promising Gene Therapy Results?
Thinking About Vertex Pharmaceuticals Stock? Here’s What You Need to Know
If you’ve been watching Vertex Pharmaceuticals lately, you’re definitely not alone. With the stock trading at $395.12, investors are wondering if the recent ups and downs signal an opportunity or a warning sign. Over the past month, Vertex has slipped around 17%. This follows multi-year returns that would make most biotechs envious. In fact, despite this recent dip, Vertex has delivered an impressive 40% total return...